January 1, 2018 by Bill Schiffner
Britt Vitalone, Chris Dimos, Cigna, Cigna Pharmacy, Health Mart, James Beer, John Hammergren, McKesson, McKesson U.S. Pharmaceutical, Steve Courtman
2018, Issue 01-01-2018, Issues, News
SAN FRANCISCO — McKesson Corp. announced two key personnel moves, including the promotion of Chris Dimos to president of retail solutions for McKesson U.S. Pharmaceutical and Specialty Health. Dimos will now oversee the Health Mart pharmacy network, taking over from Steve Courtman, who left the company to join health insurer Cigna as senior vice president
December 18, 2017 by Chain Drug Review
Britt Vitalone, James Beer, McKesson, McKesson's CFO
Business, Leading Headlines, Supplier News
SAN FRANCISCO — A new chief financial officer is slated to take the reins at McKesson Corp. starting next month. McKesson said Monday that James Beer, executive vice president and chief financial officer, is leaving the company to become CFO of Atlassian, a San Francisco-based enterprise collaboration company in February. With Beer’s departure, Britt Vitalone,
December 15, 2017 by Chain Drug Review
Chris Dimos, Cigna, Cigna Pharmacy, Health Mart, McKesson, McKesson U.S. Pharmaceutical, Steve Courtman
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
SAN FRANCISCO — McKesson Corp. has promoted Chris Dimos to president of retail solutions for McKesson U.S. Pharmaceutical and Specialty Health. With the move, Dimos will now oversee the Health Mart pharmacy network, taking over from Steve Courtman, who left the company to join health insurer Cigna as senior vice president of Cigna Pharmacy. In
December 11, 2017 by Bill Schiffner
John Hammergren, McKesson, Paul Julian
2017, Issue 12-11-2017, Issues, News
SAN FRANCISCO — Paul Julian, executive vice president and group president at McKesson Corp., is slated to retire at the end of the year. Julian currently has senior operating responsibility for McKesson’s domestic and international Distribution Solutions businesses, including pharmaceutical distribution, medical-surgical distribution, specialty health and retail pharmacy systems and automation. As president of McKesson
November 20, 2017 by Geoff Walden and Chain Drug Review
CVS Health, John Hammergren, McKesson, RxCrossroads
2017, Issue 11-20-2017, Issues, News
SAN FRANCISCO — McKesson Corp. has agreed to buy RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The deal, expected to close early next year, is valued at $735 million, or about $635 million net of the present value of incremental cash tax benefits. It will be funded by
November 7, 2017 by Bill Schiffner
CVS Health, John Hammergren, McKesson, McKesson Specialty Health, RxCrossroads
Business, Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. announced late Monday that it had signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The transaction is valued at $735 million, or approximately $635 million net of the present value ofincremental cash tax benefits, and will be funded by
October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
October 24, 2017 by Chain Drug Review
James Wiltz, John Buck, Mark Walchirk, McKesson, McKesson U.S. Pharmaceutical, Patterson Companies, pharmaceutical distribution
Business, Featured Articles, Leading Headlines, Pharmacy, Supplier News
ST. PAUL, Minn. — McKesson U.S. Pharmaceutical president Mark Walchirk is leaving the company to become president and chief executive officer of Patterson Companies Inc., a distributor serving the dental and animal health markets. Patterson said Tuesday that Walchirk is slated to start at the company on Nov. 20. He also will become a member
October 23, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, John Hammergren, McKesson, opioid abuse crisis, opioid epidemic, President Donald Trump
Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency. Trump this week is expected to formally declare the growing misuse and abuse of narcotic painkillers as a national emergency after saying this summer that he planned
October 17, 2017 by Bill Schiffner
Crystal Lennartz, Health Mart, McKesson, myHealthMart app, National Community Pharmacists Association, NCPA Annual Convention
Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — Health Mart is showcasing solutions to help independent pharmacies improve their clinical, operational and financial performance at the National Community Pharmacists Association Annual Convention. Health Mart said Tuesday that solutions highlighted at the NCPA Annual Convention, which kicked off this weekend and runs through tomorrow, include the myHealthMart mobile app, DIR Estimator
October 16, 2017 by Bill Schiffner
2017 NCPA Annual Conference, Chris Cella, Kim Diemand, McKesson, McKesson RxOwnership, McKesson U.S. Pharmaceutical, National Community Pharmacists Association, NCPA Foundation Presidential Scholarships, NCPA Pharmacy Ownership Workshops
Pharmacy, Supplier News
ORLANDO, Fla. — McKesson Corp.’s RxOwnership team is sponsoring educational programs for current and future pharmacists considering pharmacy ownership at the 2017 NCPA Annual Conference. McKesson said Monday that it has added support for the Student Ownership Boot Camp Series as part of its sponsorship, now in its eighth year, of the NCPA Pharmacy Ownership
September 26, 2017 by Chain Drug Review
Health Mart, Health Mart Town Hall meetings, McKesson, Revenue Remedies, Steve Courtman
Leading Headlines, Retail News
IRVING, Texas — Helping community pharmacies generate more clinical services revenue will be a key focus area for Health Mart as its fifth Town Hall Continuing Education (CE) series gets under way. Health Mart said it plans to host more than 80 Town Hall CE events nationwide through early 2018. The latest Town Hall series
September 6, 2017 by Chain Drug Review
Alain Arel, McKesson, McKesson Canada, McKesson Canada's Retail Banner Group, Paula Keays, Proxim, Rick Brennan, Uniprix, Uniprix acquisition
Business, Leading Headlines, Retail News
ST. LAURENT, Quebec — McKesson Corp., through its McKesson Canada subsidiary, has finalized its acquisition of Quebec drug chain Uniprix. Financial terms of the agreement weren’t disclosed. Also on Wednesday, McKesson Canada appointed Proxim president Alain Arel as president of Uniprix and Proxim, effective immediately. Philippe Duval, president and CEO of Uniprix, will continue in
September 1, 2017 by Chain Drug Review
Chris Smith, Direct Relief, Hurricane Harvey, Jim Marshall, John Hammergren, McKesson, McKesson Foundation, Thomas Tighe, World Vision
Featured Articles, Leading Headlines, Supplier News
SAN FRANCISCO — McKesson Corp. has boosted its Hurricane Harvey relief donations to more than $300,000 in support of recovery efforts in the inundated Houston area. McKesson and the McKesson Foundation late Thursday announced $100,000 cash donation to nonprofit Direct Relief and $150,000 in-kind donation of medical supplies to World Vision. The two organizations will